NASDAQ

Ironwood Pharmaceuticals, Inc. - Class A (IRWD)

♥ 574 Thanks from members

Live price chart, market sentiment, and community perspectives for Ironwood Pharmaceuticals, Inc. - Class A (NASDAQ: IRWD).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Mark CurrieFounder: Peter HechtFounder: Michael WickLeadership: Alexander Hardy (CEO)Leadership: Sloan Casey (CFO)Holder: BlackRock Inc.Holder: The Vanguard GroupHolder: FMR LLCLinzess (linaclotide)ConstellaPruritus pipeline assets#IRWD stock#Ironwood Pharmaceuticals#Linzess manufacturer#biotech company NASDAQ#gastrointestinal therapeutics